Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 2/20 | 0.43 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 6/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 6/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.37 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.36 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 3/20 | 0.35 |
| ▸ | HPGDS | O60760 | 1/20 | 0.33 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26565579 | 0.92 | PDGFRB (0.40) | HSD17B1HSD17B2NPC1RAB9ACASP3 | |
| SCHEMBL26551673 | 0.92 | CYP19A1 (0.43) | HSD17B1HSD17B2CYP11B1CYP11B2CYP19A1 | |
| SCHEMBL26555746 | 0.87 | PDGFRB (0.39) | HSD17B1HSD17B2NPC1RAB9A | |
| SCHEMBL26554742 | 0.87 | CYP19A1 (0.42) | HSD17B1HSD17B2CYP11B1CYP11B2CYP19A1 | |
| SCHEMBL26567752 | 0.87 | PGR (0.42) | HSD17B1HSD17B2NPC1CASP3SENP7 | |
| SCHEMBL26551712 | 0.85 | PDGFRB (0.49) | HSD17B1HSD17B2NPC1RAB9ACYP11B1 | |
| SCHEMBL26551641 | 0.85 | CYP11B2 (0.58) | NPC1RAB9ACYP11B1CYP11B2CYP19A1 | |
| SCHEMBL26551605 | 0.84 | KDM4E (0.43) | HSD17B1HSD17B2NPC1RAB9ACYP11B1 | |
| SCHEMBL26548334 | 0.81 | NPC1 (0.49) | HSD17B1HSD17B2NPC1CASP3SENP7 | |
| SCHEMBL26552036 | 0.81 | HSD17B1 (0.43) | HSD17B1HSD17B2NPC1RAB9ACASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | LAPTO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | AOC1, ODC1, PIEZO1 | HSD17B1 1717/4885HSD17B2 2087/4885NPC1 1199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.